Prevention and management of ovarian hyperstimulation syndrome

被引:25
|
作者
Chen, Chin-Der
Chen, Shee-Uan
Yang, Yu-Shih [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Obstet & Gynaecol, Taipei, Taiwan
关键词
ovarian hyperstimulation syndrome; complications; prevention; management; IN-VITRO FERTILIZATION; ENDOTHELIAL GROWTH-FACTOR; APPROACH AGONIST TRIGGER; FINAL OOCYTE MATURATION; GNRH AGONIST; INTRAVENOUS ALBUMIN; CYCLES; ASCITES; WOMEN; RISK;
D O I
10.1016/j.bpobgyn.2012.04.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian hyperstimulation syndrome is a relatively common complication of ovarian stimulation and can be life-threatening. The pathophysiology of ovarian hyperstimulation syndrome is characterised by increased capillary permeability, leading to leakage of fluid from the vascular compartment, with third space fluid accumulation and intravascular dehydration. The combined use of a gonadotrophin-releasing hormone antagonist protocol with gonadotrophin-releasing hormone agonist triggering and oocyte and embryo freezing has considerable promise in preventing ovarian hyperstimulation syndrome. Women with severe ovarian hyperstimulation syndrome require hospitalisation for more careful monitoring and treatment. Transvaginal paracentesis can be used as an outpatient treatment to prevent the need for hospitalisation. The inhibition of vascular permeability seems to be a novel therapeutic approach to preventing and treating ovarian hyperstimulation syndrome. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:817 / 827
页数:11
相关论文
共 50 条
  • [31] New approaches in the prevention of ovarian hyperstimulation syndrome
    Griesinger, G.
    Binder, H.
    Diedrich, K.
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2008, 6 (03): : 165 - 170
  • [32] Intravenous albumin in the prevention of ovarian hyperstimulation syndrome
    Muñoz, E
    Cuneo, S
    Ferro, J
    Vidal, C
    Pellicer, A
    Simón, C
    Remohí, J
    HUMAN REPRODUCTION, 2000, 15 : 139 - 139
  • [33] THE EFFECT OF CRYOPRESERVATION IN PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME
    TIITINEN, A
    HUSA, LM
    TULPPALA, M
    SIMBERG, N
    SEPPALA, M
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1995, 102 (04): : 326 - 329
  • [34] GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome
    Alama, Pilar
    Bellver, Jose
    Vidal, Carmen
    Giles, Juan
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2013, 11 (02) : 107 - 116
  • [35] Dopamine agonists in prevention of ovarian hyperstimulation syndrome
    Kasum, Miro
    Vrcic, Hrvoje
    Stanic, Patrik
    Jezek, Davor
    Oreskovic, Slavko
    Beketic-Oreskovic, Lidija
    Pekez, Marijeta
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (12) : 845 - 849
  • [36] Prevention of ovarian hyperstimulation syndrome: novel strategies
    Grudzinskas, JG
    Egbase, PE
    HUMAN REPRODUCTION, 1998, 13 (08) : 2051 - 2053
  • [37] Prediction and prevention of ovarian hyperstimulation syndrome (OHSS)
    Zouves, C
    Sher, G
    Sohn, S
    Barnes, F
    Maassarani, G
    Feinman, M
    IN VITRO FERTILIZATION AND ASSISTED REPRODUCTION, 1997, : 445 - 451
  • [38] THE MANAGEMENT OF SEVERE OVARIAN HYPERSTIMULATION SYNDROME
    JENKINS, JM
    MATHUR, RS
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1995, 102 (11): : 935 - 935
  • [39] The Diagnosis and Management of Ovarian Hyperstimulation Syndrome
    Shmorgun, Doron
    Claman, Paul
    Gysler, Mathias
    Hemmings, Robert
    Cheung, Anthony P.
    Goodrow, Gwendolyn J.
    Hughes, Edward G.
    Min, Jason K.
    Roberts, Jeff
    Senikas, Vyta
    Wong, Benjamin Chee-Man
    Young, David C.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2011, 33 (11) : 1156 - 1162
  • [40] Prevention of ovarian hyperstimulation syndrome by prolonged coasting
    Balet, R
    Smith, S
    Foad, F
    Knight, S
    Sawas, M
    Perks, N
    Bogdanskiene, G
    Grudzinskas, JG
    HUMAN REPRODUCTION, 1998, 13 : 175 - 176